Innovasjon ved Fysisk Institutt Turning Top Science into Products

Presentasjon om: "Innovasjon ved Fysisk Institutt Turning Top Science into Products"— Utskrift av presentasjonen:

1 Innovasjon ved Fysisk Institutt Turning Top Science into Products
Gruppelederforum 8. Februar 2013 Jonny Østensen Elin Melby Ivar Bergland

2 INNOVATION Inven2’s role is to transfer research results into innovative products for new or existing businesses Clever people Research UiO + HSØ Public research funding 5 BNOK Knowledge (publications) Knowledge-based Industries and products Inven2

3 Inven2s misjon er å skape nytt næringsliv fra resultater av forskning = teknologioverføring
Technology Strategy Business Development Finance Legal & Clinical Commercialization Business Concept Commercial Proof of Concept Technology

4 Turning Top Science into Products
Innovasjon = Idé som har kommet i praktisk bruk (produkt eller tjeneste) Oppfinnelse = Konkret beskrivelse av hvordan et produkt kan lages eller brukes (ikke bare en idé) DOFI = Disclosure of Invention = Beskrivelse av en oppfinnelse eller tjeneste og hvordan den kan bli til en innovasjon, sendes til Inven2 Patent = Rettslig beskyttelse mot «kopiering» av en oppfinnelse, spesielle regler gjelder for godkjenning. Oppfinnelsen må ikke være publisert før søknadsdato. Teknologioverføring = Overføring av rettigheter fra Universitetet til en markedsaktør Lisens: partner er et eksisterende selskap Selskapsetablering: partner er en investor Kommersialisering = Mekanisme for å finne seriøse partnere med vilje og evne til å realisere en innovasjon. Gir også tilbakebetaling til oppfinnere og forskningsmiljø = midler til videre forskning.

5 Publisering eller Patentering?
Ja, takk – begge deler Patentsøknader har strenge regler om nyhet og oppfinnelseshøyde for å kunne innvilges En oppfinnelse må ikke publiseres før den søkes patentbeskyttet Ikke send manuskripter til publisering uten først å ha kontaktet Inven2 dersom publikasjonen beskriver en mulig oppfinnelse Mange forskningsresultater kan bli til nyttige produkter også uten patentbeskyttelse, vi vil vite hva dere forsker på. Alle forskere skal ha en kontaktperson i Inven2, ta kontakt !

6 Patenter er som ost: Dess fetere dess bedre
Man må ha to tanker i hodet på en gang - hva skal vårt produkt bli og hva kan en konkurrent komme opp med? Utvidelse for beskyttelse Konkurrerende produkt mulighet Resultat i markedet = ditt produkt Resultater i dag Spissing for salg patentdekning Konkurrerende produkt mulighet

7 Kommersialisering er et virkemiddel for nyskapning
Betalingsvilje = vilje til utvikling hos partner A sustainable industry needs to be profitable. The ideas we select for development need to create profit

8 Utvikling og finansiering av innovasjonsprosjekter
(Tall for 81 UiO-DOFIer som er år gamle) Novelty? Patentability? Customer need? Market? Data support? Potential for realization? Patenting (if applicable) = Beslutning om videre utvikling

9 Innovasjonsresultater, (Inven2 totalt)
Ideas/Inventions Patent applications Commercializations 9

10 10

11 11

12 DOFIs from Department of Physics
A Novel Ischemia-detecting Device For the Intestines Ørjan Martinsen m.fl 01/22/2013 Radiation Dose optimization system Anne Cathrine Trægde Martinsen m.fl. 12/18/2012 Elimination of icing and growth of biological material on optical lenses/devices Bengt Svensson m.fl. 12/17/2012 High resolution and high sensitivity MRI compatible PET technology Erlend Bolle m.fl. 10/18/2012 Xanthates, a new class of carbonic anhydrase inhibitors Erik Pettersen m.fl. 10/10/2012 Romværparameter Jøran Moen m.fl. 08/14/2012 TGFbeta3 given after radiation exposure reduce damage 07/06/2012 multi-Needle Langmuir Probe system (m-NLP) 03/05/2012 Sensor measuring bioelectric and bioimpedance parameters simultaneously at the same site Ørjan Martinsen m.fl. 02/29/2012 Nano Oil Clean Stian Hauge 05/09/2011 Dithiocarbamates a novel class of Carbonic Anhydrase inhibitors 11/18/2011 Method to inhibit resistance and DNA intercalating agents 07/01/2010 Method to identify patients with resistance to radiation 06/29/2010 Small molecular Carbonic anhydrase-9-inhibitors (METOXIA) Multi-needle langmuir Probe System (m-NLP) 06/08/2010 Process to induce radioresistance Erik Pettersen m.fl 05/25/2010 Overvåkning av vannporter Helge Balk 05/10/2010 EUROXY: A new technology for diagnosing hypoxic cancer cells in solid tumors 04/30/2010 Removing of Li from ZnO 03/26/2010 Modified sulfonamides (METOXIA) 09/30/2009 Analyse av hemodynamiske parametre i hjernen Atle Bjørnerud m.fl 11/20/2009 Methods for obtaining reduced surface recombination velocity of silicon 05/15/2006

13 PROF. ERIK OLAI PETTERSEN
CO-INNOVATORS: Nina Edin, Peter Ebbesen, Joe Alexander Sandvik, and international collaborators PRIMARY EMPLOYMENT: Department of Physics, Biophysics and Medical Physics, UiO FIELD OF RESEARCH: Pettersen’s main area of research is the effect of ionizing radiation on living organisms, especially development and treatment of cancer. He focuses on small radiation doses and low dose rates, and in particular he has concentrated on the radiation sensitivity of cells with low avaiability of oxygen. Pettersen is highly engaged in large international research collaborations and is most successfull in acquiring EU funding for his projects. At the moment he is heading the EU project METOXIA aiming to develop methods that specifically locate and inactivate cells in hypoxic areas to obtain a cancer-specific effect selective for the most harmful of the cancer cells. INNOVATION TRACK RECORD: 9 submitted DOFIs 5 established innovation projects 4 patent applications Picture is taken from 13

14 PROF. JØRAN IDAR MOEN CO-INNOVATORS: Torfinn Lindem, Tore André Bekkeng, Espen Trondsen, Arne Pedersen, Knut S. Jacobsen PRIMARY EMPLOYMENT: Head of Department of Fysics, University of Oslo and Group Leader of the reseach group STAR (Space Technology and Research) SECONDARY EMPLOYMENT: Professor II, The University Centre in Svalbard FIELD OF RESEARCH: Moen’s main interest is studying Solar-Terrestrial coupling in the auroral cusp/ polar cap region by multi-instrument techniques, using radars and ground based optics from Svalbard, as well as satellite and sounding rockets. He is heading a sounding rocket program dedicated to study ionospheric irregularities formed by plasma instabilities in the context of cusp auroras and polar cap patches. The goal is to produce useful input data for future space weather services for communication and GNSS services. INNOVATION TRACK RECORD: 2 submitted DOFIs (related to space weather) 2 established innovation projects 1 patent application 3 license agreements with Eidel AS 1 verification project (ANCHOR) 14

15 PROF. BENGT G. SVENSSON CO-INNOVATORS: Eduoard Monakhov, Andrej Kuznetsov, Klaus Magnus Johansen PRIMARY EMPLOYMENT: Department of Fysics, UiO, and Group Leader of the Semiconductor Physics Group (LENS), Centre for Materials Science and Nanotechnology (SMN) FIELD OF RESEARCH: The overall vision is “application-motivated basic research” addressing rather fundamental materials science and physics issues but in most cases with a clear vision for long-term applications relevant to enabling technologies for renewable energy. On a more detailed level, a central ingredient is to cover the whole ‘value-chain’ from materials synthesis to realization and evaluation of test (device) structures. INNOVATION TRACK RECORD (per Dec 2012): 3 submitted DOFIs (related to zinc oxide) 2 established innovation projects 3 patent applications (incl co-ownership with REC)

16 Inven2 will help you to get the funding
The Research Council FORNY2020: Commercializing R&D results Funding Norwegian technology transfer offices and projects in need of proof-of-concept BIOTEK2021: Biotechnology for innovation Helse Sør-Øst Commercialization funding for PhD students Applications EU, NFR Writing Agreements In general: Improved focus on commercialization often leads to more industry contact, which again can open new doors for funding The Research Council FORNY2020: Commercializing R&D results Funding Norwegian technology transfer offices and projects in need of proof-of-concept BIOTEK2021: Biotechnology for innovation Helse Sør-Øst Commercialization funding for ph.d. students Applications EU, NFR Writing Agreements Picture is taken from

17 Conclusions : Largest TTO in Norway
Commercializes inventions from the University of Oslo and Oslo University Hospital Seeks partners for outlicensing and/or industrial collaborations Expects more commercial products to come out of Department of Physics Wants to learn to know you better! :

18 Contacts Elin Melby Ivar Bergland Jan Solberg Audun Torsnes Jannicke Kristoffersen Jonny Østensen